Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Overview and future prospects

J H Foster1

  • 1Department of Surgery, University of Connecticut School of Medicine, Farmington, Connecticut, USA.

Surgical Oncology Clinics of North America
|April 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Letter from J. H. Foster, M. D., Surgeon Dentist.

The American journal of dental science·2019
Same author

Address, Delivered before the Society of the Alumni of the Baltimore College of Dental Surgery.

The American journal of dental science·2019
Same author

Opening Address, Delivered before the American Society of Dental Surgeons at the Annual Meeting Held in Philadelphia, August, 1851.

The American journal of dental science·2019
Same author

Professional Shortcomings.

The American journal of dental science·2019
Same author

Dinutuximab for the treatment of pediatric patients with neuroblastoma.

Drugs of today (Barcelona, Spain : 1998)·2017
Same author

Quality of life measures in alcohol dependent subjects and changes with abstinence and continued heavy drinking.

Addiction biology·2016
Same journal

Small Incisions, Big Impact-Robotic Surgery Is Revolutionizing Cancer Care.

Surgical oncology clinics of North America·2026
Same journal

Minimally Invasive and Robotic Surgery for Cancer.

Surgical oncology clinics of North America·2026
Same journal

TeleSurgery: The Present and the Future for Minimally Invasive and Robotic Surgery.

Surgical oncology clinics of North America·2026
Same journal

Minimally Invasive and Robotic Surgery for Rectal Cancer.

Surgical oncology clinics of North America·2026
Same journal

Minimally Invasive/Robotic Surgery for Colon Cancer.

Surgical oncology clinics of North America·2026
Same journal

Minimally Invasive Surgery in Liver Transplantation.

Surgical oncology clinics of North America·2026
See all related articles

Surgical resection offers a cure for select liver cancer patients. However, current palliative treatments are often ineffective, though new advancements offer hope for improved outcomes.

Area of Science:

  • Hepatology
  • Surgical Oncology
  • Medical Oncology

Background:

  • Liver cancer presents a significant global health challenge.
  • Curative treatment options for liver cancer are limited, primarily to surgical resection.
  • Current palliative strategies for unresectable liver cancer often yield suboptimal results.

Purpose of the Study:

  • To review the current landscape of liver cancer treatment.
  • To highlight the limitations of existing palliative therapies.
  • To discuss promising recent advances in liver cancer management.

Main Methods:

  • Review of current literature on liver cancer treatment.
  • Analysis of outcomes for surgical resection.
  • Evaluation of palliative care approaches and emerging therapies.

Related Experiment Videos

Main Results:

  • Surgical resection remains the only curative option for highly selected patients with limited liver cancer.
  • Existing palliative agents and techniques demonstrate limited success in managing advanced liver cancer.
  • Recent scientific and technological advancements are showing potential to improve palliation and patient outcomes.

Conclusions:

  • Liver cancer management requires a multi-faceted approach, balancing curative and palliative strategies.
  • There is a critical unmet need for more effective palliative treatments for liver cancer.
  • Ongoing research and development in liver cancer therapeutics hold promise for future clinical practice.